6f27
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==NMR solution structure of non-bound [des-Arg10]-kallidin (DAKD)== | |
| - | + | <StructureSection load='6f27' size='340' side='right' caption='[[6f27]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6f27]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6F27 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6F27 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6f27 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6f27 OCA], [http://pdbe.org/6f27 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6f27 RCSB], [http://www.ebi.ac.uk/pdbsum/6f27 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6f27 ProSAT]</span></td></tr> | |
| - | [[Category: | + | </table> |
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/KNG1_HUMAN KNG1_HUMAN]] Congenital high-molecular-weight kininogen deficiency. The disease is caused by mutations affecting the gene represented in this entry. | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/KNG1_HUMAN KNG1_HUMAN]] (1) Kininogens are inhibitors of thiol proteases; (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action); (5) LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting. | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Glaubitz, C]] | ||
| + | [[Category: Joedicke, L]] | ||
| + | [[Category: Jonker, H R.A]] | ||
| + | [[Category: Kalavacherla, T]] | ||
| + | [[Category: Kuenze, G]] | ||
| + | [[Category: Mao, J]] | ||
[[Category: Meiler, J]] | [[Category: Meiler, J]] | ||
| - | [[Category: Glaubitz, C]] | ||
[[Category: Michel, H]] | [[Category: Michel, H]] | ||
| - | [[Category: Jonker, H.R.A]] | ||
[[Category: Preu, J]] | [[Category: Preu, J]] | ||
| - | [[Category: Mao, J]] | ||
| - | [[Category: Joedicke, L]] | ||
[[Category: Reinhart, C]] | [[Category: Reinhart, C]] | ||
| - | [[Category: Kuenze, G]] | ||
| - | [[Category: Kalavacherla, T]] | ||
[[Category: Richter, C]] | [[Category: Richter, C]] | ||
[[Category: Schwalbe, H]] | [[Category: Schwalbe, H]] | ||
| + | [[Category: Gpcr g-protein-coupled receptor peptide bradykinin kallidin human kinin]] | ||
| + | [[Category: Membrane protein]] | ||
Revision as of 08:34, 10 January 2018
NMR solution structure of non-bound [des-Arg10]-kallidin (DAKD)
| |||||||||||
